Mark Massaro
Stock Analyst at BTIG
(4.52)
# 280
Out of 4,981 analysts
142
Total ratings
52.46%
Success rate
22.35%
Average return
Main Sectors:
Stocks Rated by Mark Massaro
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CDNA CareDx | Reiterates: Buy | $22 | $13.53 | +62.60% | 3 | Sep 12, 2025 | |
| LUCD Lucid Diagnostics | Reiterates: Buy | $2.5 | $1.03 | +142.72% | 4 | Sep 10, 2025 | |
| GH Guardant Health | Maintains: Buy | $65 → $70 | $54.90 | +27.52% | 3 | Sep 4, 2025 | |
| DNA Ginkgo Bioworks Holdings | Maintains: Sell | $6 → $9 | $10.01 | -10.09% | 7 | Aug 25, 2025 | |
| TEM Tempus AI | Maintains: Buy | $75 → $85 | $86.38 | -1.60% | 3 | Aug 20, 2025 | |
| EXAS Exact Sciences | Maintains: Buy | $65 → $60 | $53.94 | +11.23% | 17 | Aug 12, 2025 | |
| MXCT MaxCyte | Downgrades: Neutral | n/a | $1.45 | - | 4 | Aug 11, 2025 | |
| ADPT Adaptive Biotechnologies | Maintains: Buy | $8 → $9 | $12.61 | -28.63% | 5 | Dec 18, 2024 | |
| BNGO Bionano Genomics | Downgrades: Neutral | n/a | $3.88 | - | 8 | Sep 10, 2024 | |
| PSNL Personalis | Maintains: Buy | $5.5 → $7 | $5.85 | +19.66% | 1 | Aug 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $220 → $225 | $148.20 | +51.82% | 2 | Aug 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $125 → $135 | $168.51 | -19.89% | 13 | Aug 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $35 → $45 | $123.95 | -63.70% | 4 | Jul 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $580 | $641.29 | -9.56% | 1 | Jul 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $23 → $21 | $7.96 | +163.82% | 4 | May 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $4.45 | - | 1 | Mar 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $8 | $3.69 | +116.80% | 8 | Mar 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $8 | $3.15 | +153.97% | 2 | Mar 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $38 → $30 | $21.42 | +40.06% | 4 | Jun 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $6 → $5 | $9.78 | -48.88% | 3 | Mar 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.23 | - | 1 | Jan 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $350 → $300 | $95.12 | +215.39% | 6 | Sep 22, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $52 → $50 | $64.45 | -22.42% | 9 | Nov 11, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $108 → $112 | $182.91 | -38.77% | 10 | Jul 24, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $155 → $165 | $277.95 | -40.64% | 10 | May 2, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $78 → $80 | $28.57 | +180.01% | 9 | Sep 10, 2018 |
CareDx
Sep 12, 2025
Reiterates: Buy
Price Target: $22
Current: $13.53
Upside: +62.60%
Lucid Diagnostics
Sep 10, 2025
Reiterates: Buy
Price Target: $2.5
Current: $1.03
Upside: +142.72%
Guardant Health
Sep 4, 2025
Maintains: Buy
Price Target: $65 → $70
Current: $54.90
Upside: +27.52%
Ginkgo Bioworks Holdings
Aug 25, 2025
Maintains: Sell
Price Target: $6 → $9
Current: $10.01
Upside: -10.09%
Tempus AI
Aug 20, 2025
Maintains: Buy
Price Target: $75 → $85
Current: $86.38
Upside: -1.60%
Exact Sciences
Aug 12, 2025
Maintains: Buy
Price Target: $65 → $60
Current: $53.94
Upside: +11.23%
MaxCyte
Aug 11, 2025
Downgrades: Neutral
Price Target: n/a
Current: $1.45
Upside: -
Adaptive Biotechnologies
Dec 18, 2024
Maintains: Buy
Price Target: $8 → $9
Current: $12.61
Upside: -28.63%
Bionano Genomics
Sep 10, 2024
Downgrades: Neutral
Price Target: n/a
Current: $3.88
Upside: -
Personalis
Aug 16, 2024
Maintains: Buy
Price Target: $5.5 → $7
Current: $5.85
Upside: +19.66%
Aug 12, 2024
Maintains: Buy
Price Target: $220 → $225
Current: $148.20
Upside: +51.82%
Aug 9, 2024
Maintains: Buy
Price Target: $125 → $135
Current: $168.51
Upside: -19.89%
Jul 31, 2024
Maintains: Buy
Price Target: $35 → $45
Current: $123.95
Upside: -63.70%
Jul 25, 2024
Initiates: Buy
Price Target: $580
Current: $641.29
Upside: -9.56%
May 2, 2024
Maintains: Buy
Price Target: $23 → $21
Current: $7.96
Upside: +163.82%
Mar 12, 2024
Downgrades: Neutral
Price Target: n/a
Current: $4.45
Upside: -
Mar 7, 2024
Maintains: Buy
Price Target: $7 → $8
Current: $3.69
Upside: +116.80%
Mar 6, 2024
Maintains: Buy
Price Target: $7 → $8
Current: $3.15
Upside: +153.97%
Jun 15, 2023
Maintains: Buy
Price Target: $38 → $30
Current: $21.42
Upside: +40.06%
Mar 22, 2023
Maintains: Buy
Price Target: $6 → $5
Current: $9.78
Upside: -48.88%
Jan 20, 2023
Downgrades: Neutral
Price Target: n/a
Current: $1.23
Upside: -
Sep 22, 2020
Maintains: Hold
Price Target: $350 → $300
Current: $95.12
Upside: +215.39%
Nov 11, 2019
Maintains: Hold
Price Target: $52 → $50
Current: $64.45
Upside: -22.42%
Jul 24, 2019
Maintains: Buy
Price Target: $108 → $112
Current: $182.91
Upside: -38.77%
May 2, 2019
Maintains: Hold
Price Target: $155 → $165
Current: $277.95
Upside: -40.64%
Sep 10, 2018
Maintains: Buy
Price Target: $78 → $80
Current: $28.57
Upside: +180.01%